(Total Views: 269)
Posted On: 01/20/2017 9:38:15 AM
Post# of 1525
Progressive Care Beats Expectations with over $18 Million in 2016 Revenues
Date : 01/20/2017 @ 8:30AM
Source : InvestorsHub NewsWire
Stock : Progressive Care, Inc. (PC) (RXMD)
Quote : 0.02956 0.0 (0.00%) @ 8:03AM
MIAMI, FL -- January 20, 2017 -- InvestorsHub NewsWire -- Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary Pharmco, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record breaking 2016.
PharmCo closed out 2016 with revenues of $1.7 million and 18,000 prescriptions filled during the month of December. This was a 20% and 6% increase respectively over the same period last year. The Companys strong December brought annual revenues to over $18 million on approximately 215,000 prescriptions filled in the pharmacy, which is a 34% and 20% increase respectively over 2015. Sales performance outpaced annual expectations by approximately $2 million.
We could not have asked for a better 2016, stated S. Parikh Mars, CEO. We set ambitious goals at the beginning of the year and always believed that we could accomplish them. Our sales represent the success of our pharmacy model and what we believe a pharmacy should be in the new healthcare climate.
Date : 01/20/2017 @ 8:30AM
Source : InvestorsHub NewsWire
Stock : Progressive Care, Inc. (PC) (RXMD)
Quote : 0.02956 0.0 (0.00%) @ 8:03AM
MIAMI, FL -- January 20, 2017 -- InvestorsHub NewsWire -- Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary Pharmco, LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record breaking 2016.
PharmCo closed out 2016 with revenues of $1.7 million and 18,000 prescriptions filled during the month of December. This was a 20% and 6% increase respectively over the same period last year. The Companys strong December brought annual revenues to over $18 million on approximately 215,000 prescriptions filled in the pharmacy, which is a 34% and 20% increase respectively over 2015. Sales performance outpaced annual expectations by approximately $2 million.
We could not have asked for a better 2016, stated S. Parikh Mars, CEO. We set ambitious goals at the beginning of the year and always believed that we could accomplish them. Our sales represent the success of our pharmacy model and what we believe a pharmacy should be in the new healthcare climate.
(0)
(0)
